(PharmaNewsWire.Com, May 12, 2017 ) As per the syndicated report published by Market Data Forecast Europe Diabetic Retinopathy Market which is estimated to be USD 1.10 billion in 2016 is poised to reach USD 1.51 billion by 2021, at a CAGR of 6.55% from 2016 to 2021. It can attribute to the factors such as abundant R&D activities, government initiatives, and skill set enhancement of healthcare providers. Such supportive initiatives coupled with increasing awareness among patients are anticipated to result in lucrative growth. Treatment of diabetic retinopathy is expected to gain patients willingness for treatment by introducing advanced technology with quick recovery time and reducing pain by using laser procedure.
Diabetic retinopathy is a medical condition which damages retina and leads to blindness if undiagnosed or untreated. The degree of treatment of diabetic retinopathy varies according to various stages of the disease and is mainly prioritized to curb the disease at its initial stage.
Europe Diabetic Retinopathy Market is segmented based on Type of Treatment, Indication and End Users as mentioned below for attaining a more granular perspective of the market. In the report each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Type of Treatment: • Anti-Vascular Endothelial Growth Factor (VEGF) drug • Intraocular Steroid Injection • Laser Surgery • Vitrectomy
Based on Indication: • Non-Proliferative Diabetic Retinopathy (NPDR) o Mild o Moderate o Severe • Proliferative Diabetic Retinopathy (PDR)
Based on End Users: • Hospitals • Ophthalmic Clinics • Ambulatory Surgical Centers
The European diabetic retinopathy market holds the highest share in the market, driven by rising patient awareness levels, particularly in the Western European countries. Europe market is geographically segmented into Spain, Germany, Italy, UK and France.
The key players in Europe Diabetic Retinopathy Market are Pfizer Inc., Bayer AG, Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Abbott Laboratories Inc., Alimera Science Inc., Novartis AG, Valeant Pharmaceutical International Inc., and Ampio Pharmaceuticals Inc.
Further, technological breakthroughs in retinal screening methods and equipment like utilization of slit lamps and launching of new products like Gly-230 & Optima are the factors predicted to lead the industry expansion. Growing occurrence of diabetes predicted to affect more than 4.6% of world population will also improve the industry growth.
The Diabetic Retinopathy Market study offers the following deliverables:
• Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries
• Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis
• Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porter’s Five Forces Analyses
• Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Check out other related studies in the Therapeutics Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
